7Baggers
 D. Boral Capital Reaffirms Buy Rating for Humacyte (NASDAQ:HUMA)  MarketBeat Tue, 30 Sep 2025 12:20:06 GMT
 HUMA Stock Sees Analyst 'Buy' Rating Maintained by D. Boral Capi  GuruFocus Tue, 30 Sep 2025 11:46:17 GMT
 Humacyte (HUMA) Price Target Increased by 51.64% to 9.44  Nasdaq Tue, 30 Sep 2025 11:42:00 GMT
 Humacyte secures patent for bioengineered esophagus technology  Investing.com Mon, 29 Sep 2025 15:34:52 GMT
 huma - humacyte inc latest stock news & market updates  Stock Titan Mon, 29 Sep 2025 12:00:00 GMT
 analysts set humacyte, inc. (nasdaq:huma) pt at $9.29  MarketBeat Wed, 24 Sep 2025 06:00:34 GMT
 analysts set humacyte, inc. (nasdaq:huma) pt at $9.29  MarketBeat Tue, 23 Sep 2025 07:00:00 GMT
 with humacyte up 27%, insider buyers count their returns  富途牛牛 Sun, 21 Sep 2025 07:00:00 GMT
 humacyte (nasdaq:huma) earns buy rating from d. boral capital  MarketBeat Sat, 20 Sep 2025 00:22:30 GMT
 Here's Why Humacyte (NASDAQ:HUMA) Can Afford Some Debt  simplywall.st Fri, 19 Sep 2025 07:00:00 GMT
 humacyte (nasdaq:huma) earns buy rating from d. boral capital  MarketBeat Fri, 19 Sep 2025 07:00:00 GMT
 humacyte prices $30m securities offering  MSN Thu, 18 Sep 2025 21:14:46 GMT
 woodline partners lp raises holdings in humacyte, inc. $huma  MarketBeat Thu, 18 Sep 2025 07:44:43 GMT
 Humacyte Amends Revenue Agreement with TPC Investments  TipRanks Thu, 18 Sep 2025 07:00:00 GMT
 humacyte’s engineered vessel shows promise in coronary bypass study  Investing.com Thu, 18 Sep 2025 07:00:00 GMT
 humacyte announces preclinical data on ctev use  TipRanks Thu, 18 Sep 2025 07:00:00 GMT
 institution moves: does humacyte inc. stock have upside surprise potential  خودرو بانک Wed, 17 Sep 2025 00:43:02 GMT
 humacyte's (huma) "buy" rating reiterated at d. boral capital  MarketBeat Tue, 16 Sep 2025 13:51:34 GMT
 humacyte, inc. $huma shares purchased by woodline partners lp  MarketBeat Mon, 15 Sep 2025 08:29:40 GMT
 Humacyte reports positive outcomes for Symvess in vascular repairs  Investing.com Mon, 15 Sep 2025 07:00:00 GMT
 Humacyte files $350M mixed securities shelf  MSN Fri, 12 Sep 2025 21:29:06 GMT
 humacyte inc files for mixed shelf of up to $350 million - sec filing  MarketScreener Fri, 12 Sep 2025 07:00:00 GMT
 294,392 shares in humacyte, inc. $huma bought by nuveen llc  MarketBeat Wed, 10 Sep 2025 18:56:53 GMT
 294,392 shares in humacyte, inc. $huma purchased by nuveen llc  MarketBeat Wed, 10 Sep 2025 07:00:00 GMT
 nuveen llc purchases new position in humacyte, inc. $huma  MarketBeat Wed, 10 Sep 2025 01:36:39 GMT
 published on: 2025-09-03 06:28:25  Newser Wed, 03 Sep 2025 11:28:25 GMT
 published on: 2025-09-03 02:22:53  Newser Wed, 03 Sep 2025 07:22:53 GMT
 humacyte (nasdaq:huma) now covered by barclays  MarketBeat Wed, 03 Sep 2025 07:00:00 GMT

Humacyte, Inc.
(NASDAQ:HUMA) 

HUMA stock logo

Humacyte, Inc., a clinical-stage biotechnology platform company, develops and manufactures off-the-shelf bioengineered human tissues. The company develops and manufactures acellular tissues to address life- and limb-threatening vascular conditions for complex organ disease. Its Human Acellular Vesse...

Founded: 2004
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends